A scavenger peptide prevents methylglyoxal induced pain in mice

The reactive metabolite methylglyoxal (MG) has been identified as mediator of pain. Scavenging of free MG and the prevention of MG-derived post-translational modifications may provide a useful therapeutic treatment. An arginine-rich, fatty acid coupled, cyclic peptide (CycK(Myr)R4E) with high proteo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Brings, Sebastian (VerfasserIn) , Fleming, Thomas (VerfasserIn) , Beijer, Barbro (VerfasserIn) , Lindner, Thomas (VerfasserIn) , Wischnjow, Artjom (VerfasserIn) , Kender, Zoltán (VerfasserIn) , Peters, Verena (VerfasserIn) , Kopf, Stefan (VerfasserIn) , Haberkorn, Uwe (VerfasserIn) , Mier, Walter (VerfasserIn) , Nawroth, Peter Paul (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2017
In: Biochimica et biophysica acta. Molecular basis of disease
Year: 2017, Jahrgang: 1863, Heft: 3, Pages: 654-662
ISSN:1879-260X
DOI:10.1016/j.bbadis.2016.12.001
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.bbadis.2016.12.001
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0925443916303295
Volltext
Verfasserangaben:Sebastian Brings, Thomas Fleming, Svenja De Buhr, Barbro Beijer, Thomas Lindner, Artjom Wischnjow, Zoltan Kender, Verena Peters, Stefan Kopf, Uwe Haberkorn, Walter Mier, Peter P. Nawroth
Beschreibung
Zusammenfassung:The reactive metabolite methylglyoxal (MG) has been identified as mediator of pain. Scavenging of free MG and the prevention of MG-derived post-translational modifications may provide a useful therapeutic treatment. An arginine-rich, fatty acid coupled, cyclic peptide (CycK(Myr)R4E) with high proteolytic stability and prolonged circulation was developed for the scavenging of MG. It was shown to reduce the formation of albumin-MG adducts in vitro and prevented MG-induced pain by reducing plasma MG levels through the formation of peptide-MG adducts in vivo. CycK(Myr)R4E therefore presents a promising option for the treatment of pain and other diabetic complications associated with high MG levels.
Beschreibung:Available online: 6 December 2016
Gesehen am 19.07.2018
Beschreibung:Online Resource
ISSN:1879-260X
DOI:10.1016/j.bbadis.2016.12.001